The effects of hydroxyethyl starch solution in critically ill patients;Gli effitti dell'idrossietilamido nei pazienti critici

Minerva Anestesiologica

Volumn 72, Issue 7-8, 2006, Pages 655-664

  Palumbo, D ^a   Servillo, G ^a   D'Amato, L ^a   Volpe, M L ^a   Capogrosso, G ^a   De Robertis, E ^a   Piazza, O ^a   Tufano, R ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Colloid solutions; Intensive car unit; Sepsis

Indexed keywords

ALBUMIN; DOPAMINE; HETASTARCH; NORADRENALIN; OXYGEN;

ADULT; AGE; AGED; ARTERIAL OXYGEN TENSION; ARTICLE; BLOOD GAS ANALYSIS; CLINICAL ARTICLE; CLINICAL TRIAL; COLLOID; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRITICAL ILLNESS; DRUG EFFECT; FEMALE; FLUID THERAPY; GENDER; HEART RIGHT VENTRICLE EJECTION FRACTION; HEMODYNAMICS; HUMAN; HYPOVOLEMIA; INTENSIVE CARE UNIT; LUNG CAPILLARY PRESSURE; LUNG EDEMA; MALE; MONITORING; OXYGEN CONSUMPTION; RANDOMIZED CONTROLLED TRIAL; RESUSCITATION; SCORING SYSTEM; SEPSIS;

ADULT; AGED; AGED, 80 AND OVER; ALBUMINS; CRITICAL CARE; CRITICAL ILLNESS; FEMALE; HEMODYNAMIC PROCESSES; HETASTARCH; HUMANS; MALE; MIDDLE AGED; OXYGEN INHALATION THERAPY; PLASMA SUBSTITUTES; SEPSIS;

EID: 33747400559     PISSN: 03759393     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Kirkpatrik CJ, Klosterhalfen B, Hauptmann S. The role of the endothelium in multiple organ failure. In: Vincent JL, editor. Yearbook of intensive care and emergency medicine, Berlin: Springer; 1992. p.14-24.
2. Fiddian-Green RG. Association between intramucosal acidosis in the gut and organ failure. Crit Care Med 1993;21:3-7.
3. Landow L, Andersen LW. Splanchnic ischaemia and its role in multiple organ failure. Acta Anaesthesiol Scand 1994;38:626-39.
4. Moore FA. Post traumatic complications and changes in blood lymphocytes after multiple trauma. Crit Care Med 1999;27:674-5.
5. Peitzman AB, Udekwu AO, Ochoa J, Smith S. Bacterial translocation in trauma patients. J Trauma 1991;31: 1083-6.
6. Edouard AR, Degremont AC, Duranteau J, Pussard E, Berdeaux A, Samii K. Heterogenous regional vascular responses to stimulated transient hypovolemia in man. Intensive Care Med 1994;20:414-20.
7. Tulli G. Critical points for sepsis management at the patients bedside. Minerva Anestesiol 2003;69:35-56, 56-65.
8. Gattinoni L, Vagginelli F, Taccone P, Carlesso E, Bertoja E. Sepsis: state of the art. Minerva Anestesiol 2003;69: 539-54, 554-61.
9. Brinkmeyer S, Safer P, Motoyama E. Superiority of colloids over electrolyte solution for fluid resuscitation (severe normovolemic hemodiluition). Crit Care Med 1981;9:369-74.
10. Karanko MS, Klossner JA, Laaksonen VO. Restoration of volume by crystalloids versus colloid after coronary artery bypass: hemodynamics, lung water, oxygenation, and outcome. Crit Care Med 1987;15:559-66.
11. Rackow EC, Falk JL, Fein A. Fluid resuscitation in circulatory shock: a comparison of the cardirespiratory effects of albumin, hetastarch, and saline solution in patients with hypovolemic septic shock. Crit Care Med 1983;11:839-50.
12. Bland JM, Altman DG. Statistics notes: the odds ratio BMJ 2000;320:1468.
13. Snell EJ, Parillo JE. Cardiovascular dysfunction in septic shock. Chest 1991;99:1000-9.
14. Vincent JL, van der Linden P. Septic shock: particular type of circulatory failure. Crit Care Med 1990;18 (Suppl):S70-4.
15. Falchi S, Adembri C, Marinelli L, Tani R, Novelli GP. Comparison of crystalloids and hydroxyethyl starch during normovolemic hemodilution. A study of hemodynamics and saturation measurement. Minerva Anestesiol 1992;58:145-9.
16. Boldt J. Hydroxyethyl starch: pharmaceutical and clinical profile. Minerva Anestesiol 1999;65:305-9.
17. Sibbald WJ. Fluid therapy in sepsis. In: Reinhart K, Eyrich K, Sprung C, editors. Sepsis - current prospectives in pathophysiology and therapy. Update in intensive care medicine and emergency. Vol 18. Berlin: Springer;1994. p. 266-73.
18. Rackow EC, Kaufman BS, Falk JL, Astiz ME, Weil MH. Hemodynamic response to fluid depletion in patients with septic shock: evidence for early depression of cardiac performance. Circ Shock 1987;22:11-22.
19. Kaufman BS, Rackow EC, Falk JL. The relationship between oxygen delivery and consumption during fluid resuscitation of hypovolemic shock. Chest 1984;85: 336-40.
20. Haupt MT, Gilbert EM, Carlson RW. Fluid loading increases oxygen consumption in septic patients with lactic acidosis. Am Rev Resp Dis 1985;131:912-6.
21. Carcillo JA, Davis AL, Zaritsky A. Role of early fluid resuscitation in pediatric septic shock. JAMA 1991;266: 1242-5.
22. Hillman K, Bishop G, Bristow P. The crystalloid versus colloid controversy: Present status. Baillière's Clin Anaesthesiol 1997;11:1-13.
23. Velanovich V. Crystalloid versus colloid fluid resuscitation: a meta-analysis of mortality. Surgery 1989;105: 65-71.
24. Schierhout G, Roberts I. Fluid resuscitation with colloid or crystalloid solutions in critically ill patients: a systematic review of randomised trials. Br Med J 1998;316:961-4.
25. Choi PT, Yip G, Quinonez LG, Cook DJ. Crystalloid vs colloids in fluid resiscitation: a systematic review. Crit Care Med 1999;27:200-10.
26. Haljamäe H. Synthetic colloids. Crystalloid versus colloids: The controversy. In: Baron JF, editor. Transfusion medicine and alternatives to transfusion. Paris: J. Editions Médicales; 2000. p. 113-22.
27. Grootendorst AF, van Wilgenburg MH, van de Laat PH, van der Hoven B. Albumin abuse in intensive care medicine. Intensive Care Med 1988;14:554-7.
28. Erstad BL, Gales BJ, Rappaport WD. The use of albumin in clinical practice. Arch Intern Med 1991;151: 901-11.
29. Blackburn GL, Driscoll DF. Time to abandon routine albumin supplementation. Crit Care Med 1992;20: 157-8.
30. Haljamäe H. Albumin: To use or non to use? Contemporary alternatives? In: Baron JF, Treib J, editors. Volume replacement. Berlin: Springer-Verlag;1998. p.1-22.
31. Margarson MP, Soni N. Serum albumin: touchstone or totem? Anaesthesia 1998;53: 789-803.
32. Cochrane Injuries Group Albumin Reviewers. Human albumin administration in critically ill patients: systemic review of randomised controlled trials. Br Med J 1998; 317:235-40.
33. Thompson WL, Britton JJ, Walton RP. Persistance of starch derivatives and dextrans when infused after hemorrhage. J Pharmacol Exp Ther 1962;136: 126-32.
34. Puri VK, Paidipaty B, White L. Hydroxyethyl starch for resuscitation of patients with hypovolemia and shock. Crit Care Med 1981;9:833-7.
35. Boldt J, Heesen M, Müller M, Pabsdorf M, Hempelmann G. The effects of albumin versus hydroxyethyl starch solution on cardiorespiratory and circulatory variables in critically ill patients. Anaesth Analg 1996;83:254-61.
36. Collis RE, Collins PW, Gutteridge CN, Kaul A, Newland AC, Williams DM et al. The effect of hydroxyethyl starch and other plasma volume substitutes on endothelial cell activation; an in vitro study. Intensive Care Med 1994;20:37-41.
37. Engler FL, Dahlgren MD, Morris D, Peterson MA, Schmid-Schoenbein GW. Role of leukocytes in the response to acute myocardial ischemia and reflow in dogs. Am J Physiol 1991;251:314-23.
38. Zikria BA, Subbarao C, Oz MC, Popilkis SJ, Sachdev R, Chauhan P, et al. Hydroxyethyl starch macromolecules reduce myocardial reperfusion injury. Arch Surg 1990; 125:930-4.
39. Zikria BA, King TC, Stanford J, Freeman HP. A biophysical approach to capillary permeability. Surgery 1989;105:625-31.
40. Wisselink W, Patetsios P, Panetta TF, Ramirez JA, Rodino W, Kirwin JD, et al. Medium molecular weight pentastarch reduces reperfusion injury by decreasing capillary leak in an animal model of spinal cord ischemia. J Vasc Surg 1998;27:109-16.
41. Oz MC, FitzPatrick MF, Zikria BA, Pinsky DJ, Duran WN. Attenuation of microvascular permeability dysfunction in postischemic striated muscle by hydroxyethyl starch. Microvasc Res 1995;50:71-9.
42. Oz MC, Zikria BA, McLeod PF, Popilkis SJ. Hydroxyethyl starch macromolecules and superoxide dismutase effects on myocardial reperfusion injury. Am J Surg 1991;162:59-62.
43. Zikria BA, Subbarao C, Oz MC, Shih ST, McLeod PF, Sachdev R et al. Macromolecules reduce abnormal microvacsular permeability in rat limb ischemia-reperfusion injury. Critic Care Med 1989;17:1306-9.